These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28082455)

  • 1. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving genomics-based predictions for precision medicine through active elicitation of expert knowledge.
    Sundin I; Peltola T; Micallef L; Afrabandpey H; Soare M; Mamun Majumder M; Daee P; He C; Serim B; Havulinna A; Heckman C; Jacucci G; Marttinen P; Kaski S
    Bioinformatics; 2018 Jul; 34(13):i395-i403. PubMed ID: 29949984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IntegratedMRF: random forest-based framework for integrating prediction from different data types.
    Rahman R; Otridge J; Pal R
    Bioinformatics; 2017 May; 33(9):1407-1410. PubMed ID: 28334269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning.
    Gönen M; Margolin AA
    Bioinformatics; 2014 Sep; 30(17):i556-63. PubMed ID: 25161247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
    Ali M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines.
    Basu A; Mitra R; Liu H; Schreiber SL; Clemons PA
    Bioinformatics; 2018 Oct; 34(19):3332-3339. PubMed ID: 29688307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.
    Ammad-Ud-Din M; Khan SA; Malani D; Murumägi A; Kallioniemi O; Aittokallio T; Kaski S
    Bioinformatics; 2016 Sep; 32(17):i455-i463. PubMed ID: 27587662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
    Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
    Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
    Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
    BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal drug prediction from personal genomics profiles.
    Sheng J; Li F; Wong ST
    IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating gene set analysis and nonlinear predictive modeling of disease phenotypes using a Bayesian multitask formulation.
    Gönen M
    BMC Bioinformatics; 2016 Dec; 17(Suppl 16):0. PubMed ID: 28105911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kernelized rank learning for personalized drug recommendation.
    He X; Folkman L; Borgwardt K
    Bioinformatics; 2018 Aug; 34(16):2808-2816. PubMed ID: 29528376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine.
    Kim HS; Sung YJ; Paik S
    Yonsei Med J; 2015 Sep; 56(5):1186-98. PubMed ID: 26256959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modeling.
    Yu J; Silva J; Califano A
    Bioinformatics; 2016 Jan; 32(2):260-7. PubMed ID: 26415723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
    Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.